360° Coverage : Reviewing An Aggressive Strategy In A Volatile Market

2 Updates
Reviewing An Aggressive Strategy In A Volatile Market
Photo Credit: Forbes Business

Reviewing An Aggressive Strategy In A Volatile Market

Apr 11 2014, 8:17am CDT | by

At the onset of 2014, I recommended an investment strategy of being aggressive but diversified, and introduced the Marketocracy Explore Team as one way to implement that strategy. The Explore team...

Filed under: news

 
 
 

27 weeks ago

Reviewing An Aggressive Strategy In A Volatile Market

Apr 11 2014, 8:17am CDT | by

At the onset of 2014, I recommended an investment strategy of being aggressive but diversified, and introduced the Marketocracy Explore Team as one way to implement that strategy. The Explore team consists of three to five Marketocracy Masters with proven, long-term investment track records who are performing well in the current market and exhibit little to no overlapping holdings in their portfolios.

For more information about the Marketocracy Explore Team, visit our website today.

At the close of Q1, it’s now time to review the team’s performance to see if any course corrections would be beneficial.

Marketocracy Explore Team

For comparison, the S&P 500 year-to-date through April 4, 2014 was up 1.81%.

An account that started the year with equal amounts invested in the four team members’ portfolios would be up 1.20%.

At the top level, the market beat the team by a little for the first quarter. But, an aggressive team seeking superior returns must be allowed to take risks. If those risks result in a small degree of underperformance during a volatile quarter, it is an acceptable price to pay if the strategy plays out as we expect over a reasonable investment horizon.

Digging down one level, we see that two team members (crossy:CIAF and ahknaten:KAI) more than doubled the market’s return. In my view, this indicates that their two investment styles are working well in the current market. Kai Petainen’s quantitative investment style seems to have anticipated the market’s recent shift in focus from growth to value stocks. JetBlue (NASDAQ:JBLU) and the four other value stocks showing growth Kai discussed in a previous article should benefit as “value” oriented institutional investors attract more capital.

One team member (mkoza:TGF) outperformed the market slightly. Mike Koza, much like Warren Buffett, is a fundamental value investor who buys stocks when they are cheap and out of favor. When the cheap and out of favor stocks Mike has selected outperform the market — even by a little — it is worth noting, as it is often the first sign that the market is beginning to change its assessment of Mike’s holdings. Mike generates great returns when his stocks go from ignored and undervalued to popular and fairly (or overly) valued. I think his track record, both long-term and recent, warrants keeping him on the team.

Now comes the hard decision. We have one team member (huyehara:HMF) who significantly underperformed. Justin Uyehara’s portfolio has been hurt by his position in Nektar Therapeutics (Nasdaq:NKTR), a biotech stock which is about 11% of Justin’s portfolio and is down about 20% in the past month. This position accounts for about one-half of Justin’s loss this quarter. Generally speaking, Justin — the ultimate swing trader — quickly sells stocks that start to move against him. Nektar is unusual for Justin in that it is a long-term holding. Even after the setback this past month, Justin is still up about 23% on this position.

Digging into Nektar, there does not appear to be any company-specific news to account for the drop in value. The stock is not falling because of a failed clinical trial or an adverse FDA decision. Instead, money seems to be coming out of biotech stocks as a group.

According to Bloomberg, 7.5% of the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), the biggest biotech-focused ETF, were redeemed on April 4. When an ETF gets orders to redeem its shares, it has no choice but to sell its holdings indiscriminately across the board. When you have to sell 7.5% of a $5 billion ETF, you have to place a lot of sell orders. Many biotech names do not have a deep enough market to absorb this kind of selling without driving the price down in a big way. Kerx Pharmaceuticals (NASDAQ:KERX), one of Mike Koza’s stocks, also seems to have gotten caught in the biotech selloff. This kind of selling can create lots of buying opportunities for investors who do their own research.

When it comes to managing teams of investment masters, I’ve learned that it is best to give the people with the track records a lot of latitude to make the day-to-day decisions on what stocks to buy, when to buy them, and how much to buy. Since the loss in Nektar is not company specific, it may be short-term, and indeed may be a buying opportunity. I will let Justin make that call.

My role is to make sure that the right Masters are on the team to accomplish its objectives. In Justin’s case, the fact that he was up 61.8% last year puts the 10.01% loss last quarter in perspective. Since the team overall has lagged the market only slightly, I don’t see a need to make drastic changes, therefore I am inclined to keep Justin on the team.

The opinions expressed in these articles are general in nature and not specific to your financial situation. If you would like to discuss your financial objectives, contact Ken Kam through LinkedIn.

Disclosure: I am the portfolio manager for mutual and hedge funds advised by Marketocracy Capital Management, an SEC registered investment advisor. Before relying on the opinions expressed in this article, you should assume that Marketocracy, its affiliates, clients, and I have material financial interests in these stocks and may hold or trade them contrary to these opinions when, in our view, market conditions change.

 
Update
2

7 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workforce of 20,000 ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

7 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the doub ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

WHO declares Nigeria officially Ebola-free (Roundup)
Abuja/Dar-es-Salam/Tokyo, Oct 20 (IANS) The World Health Organisation (WHO) Monday officially declared Nigeria Ebola-free , after no new cases were confirmed in the past 42 days, even as the International Monetary Fund (IMF) appealed to the donor community to provide grants to countries affected by the deadly virus.
 
 
IMF appeals for help to Ebola-hit countries
Dar-es-Salam, Oct 20 (IANS) The International Monetary Fund (IMF) Monday appealed to the donor community to provide grants to countries affected by the Ebola outbreak to avoid a decline in their economies.
 
 
Japanese firm to produce more drug for Ebola
Tokyo, Oct 20 (IANS) Japan's Fujifilm Holdings Corporation announced Monday that it will start production of the anti-influenza drug Avigan in preparation for a larger number of patients infected with the Ebola virus.
 
 
Algeria denies Ebola detection reports
Algiers, Oct 20 (IANS) Algeria Monday denied reports of detection of Ebola virus cases in its territory, media reported.
 
 
 

Latest from the Network

1,074 new dengue cases in Chinese province
Beijing, Oct 18 (IANS) China's Guangdong province has reported 1,047 new cases of dengue fever, health authorities said Saturday. Six people have already died in Guangdong -- five in Guangzhou and one in adjacent...
Read more on Business Balla
 
Blake Lively 'always' wanted to be mum
Blake Lively has ''always'' wanted to be a mother. The 27-year-old actress is expecting her first child with husband Ryan Reynolds and she admits she's been dreaming of this moment since she was a youngster. Speaking...
Read more on Celebrity Balla
 
Kris Jenner 'torn apart' by Bruce's new relationship
Kris Jenner feels ''torn apart and angry'' that Bruce Jenner is dating her former assistant. The 58-year-old matriarch split from the 64-year-old Olympic gold medalist last October following 22-years of marriage but is...
Read more on Celebrity Balla
 
Cheryl Fernandez-Versini won't move to France
Cheryl Fernandez-Versini doesn't want to move to her husband's home country of France. The 'X Factor' judge, 31, who comes from Newcastle, is adamant she won't be relocating any time soon to suit her new spouse Jean-...
Read more on Celebrity Balla
 
Lance Bass sets wedding date
Lance Bass has set a date for his wedding. The former *NSYNC singer and his partner Michael Turchin, who have been dating for two-and-a-half years, are to tie the knot on December 20, 2014, a representative for the...
Read more on Celebrity Balla
 
Nepal avalanche toll reaches 39
Kathmandu, Oct 18 (IANS) At least 39 climbers died while hiking on a key Nepali route after it was hit by a major snowstorm and avalanches earlier this week, BBC reported Saturday citing officials. Over 350 stranded...
Read more on Politics Balla
 
Jake Gyllenhaal says society is complicit in 'nightcrawling'
Jake Gyllenhaal says almost everybody in society ought to relate to his new movie 'Nightcrawlers'. The eagerly-awaited film concerns those people who monitor police scanners and then race to crime scenes to film eye-...
Read more on Movie Balla
 
India eves look for first win in AFC U-16 qualifiers
Dhaka, Oct 18 (IANS) India will hope to register their first win of the 2015 Asian Football Confederation (AFC) Under-16 Women's Championship qualifiers when they take on hosts Bangladesh in a crucial encounter at the...
Read more on Sport Balla
 
Moyes mulling return to management
London, Oct 18 (IANS) Former Manchester United manager David Moyes said that he is ready to revive his managerial career six months after being sacked by the 'Red Devils'. "I am ready to return. I have enjoyed the...
Read more on Sport Balla
 
Ebola fears loom over Ghana hosting AFCON
Accra (Ghana), Oct 18 (IANS) The Ghana Medical Association (GMA) cautioned the government Saturday against hosting the 2015 African Cup of Nations (AFCON), despite a request by the Confederation of African Football (...
Read more on Sport Balla